Table 3.

The Post-hoc analysis (least significant difference) comparing IGF-1 serum levels for each of the 6 CVMI stages

CVMI Stage	CVMI Stage	Mean Difference	Significance
1	2	−27.5*	0.000(**)
	3	−222.3*	0.000(**)
	4	−151.5*	0.000(**)
	5	−113.6*	0.000(**)
	6	−27.5*	0.000(**)
2	1	27.5*	0.000(**)
	3	−194.8*	0.000(**)
	4	−123.9*	0.000(**)
	5	−86.07*	0.000(**)
	6	−.02	0.996(NS)
3	1	222.3*	0.000(**)
	2	194.8*	0.000(**)
	4	70.8*	0.000(**)
	5	108.7*	0.000(**)
	6	194.8*	0.000(**)
4	1	151.5*	0.000(**)
	2	123.9*	0.000(**)
	3	−70.8*	0.000(**)
	5	37.9*	0.000(**)
	6	123.9*	0.000(**)
5	1	113.6*	0.000(**)
	2	86.07*	0.000(**)
	3	−108.7*	0.000(**)
	4	−37.9*	0.000(**)
	6	86.04*	0.000(**)
6	1	27.5*	0.000(**)
	2	0.02	0.996(NS)
	3	−194.8*	0.000(**)
	4	−123.9*	0.000(**)
	5	−86.04*	0.000(**)

(**) Highly significant (P < 0.01, P < 0.001),(*) Significant (P < 0.05), NS (Non significant)